NFκB can confer chemotherapy or radiotherapy resistance on cancer cells by inhibiting TRAF1 (Tumor necrosis factor receptor (TNFR) associated factor 1) and other mechanisms of cell death [5]. The gene discussed is NFKB1; the disease is cancer.